184 related articles for article (PubMed ID: 17435112)
1. Reversal of autoimmune disease in lupus-prone New Zealand black/New Zealand white mice by nonmyeloablative transplantation of purified allogeneic hematopoietic stem cells.
Smith-Berdan S; Gille D; Weissman IL; Christensen JL
Blood; 2007 Aug; 110(4):1370-8. PubMed ID: 17435112
[TBL] [Abstract][Full Text] [Related]
2. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
Good RA
World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation for autoimmune diseases.
Ikehara S
Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
[TBL] [Abstract][Full Text] [Related]
4. Stem cell transplantation for severe autoimmune diseases: progress and problems.
Marmont AM
Haematologica; 1998 Aug; 83(8):733-43. PubMed ID: 9793258
[TBL] [Abstract][Full Text] [Related]
5. Induction of chimerism and tolerance using freshly purified or cultured hematopoietic stem cells in nonmyeloablated mice.
Emmanouilidis N; Larsen CP
Methods Mol Med; 2005; 109():459-68. PubMed ID: 15585938
[TBL] [Abstract][Full Text] [Related]
6. Successful prevention of autoimmune disease by transplantation of adequate number of fully allogeneic hematopoietic stem cells.
El-Badri NS; Wang BY; Steele A; Cherry ; Marikar Y; Mizobe K; Good RA
Transplantation; 2000 Sep; 70(6):870-7. PubMed ID: 11014640
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of hematopoietic stem cells from autoimmune-prone mice and the role of neural cell adhesion molecules in abnormal proliferation of these cells in MRL/lpr mice.
Wang X; Hisha H; Cui W; Song C; Mizokami T; Okazaki S; Li Q; Feng W; Kato J; Jiang S; Fan H; Ikehara S
Haematologica; 2007 Mar; 92(3):300-7. PubMed ID: 17339178
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
[TBL] [Abstract][Full Text] [Related]
9. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
Early GS; Zhao W; Burns CM
J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation in autoimmune diseases: the Ahmedabad experience.
Vanikar AV; Modi PR; Patel RD; Kanodia KV; Shah VR; Trivedi VB; Trivedi HL
Transplant Proc; 2007 Apr; 39(3):703-8. PubMed ID: 17445577
[TBL] [Abstract][Full Text] [Related]
12. Aberrant IgM signaling promotes survival of transitional T1 B cells and prevents tolerance induction in lupus-prone New Zealand black mice.
Roy V; Chang NH; Cai Y; Bonventi G; Wither J
J Immunol; 2005 Dec; 175(11):7363-71. PubMed ID: 16301643
[TBL] [Abstract][Full Text] [Related]
13. Nonmyeloablative bone marrow transplantation of BXSB lupus mice using fully matched allogeneic donor cells from green fluorescent protein transgenic mice.
Jones OY; Steele A; Jones JM; Marikar Y; Chang Y; Feliz A; Cahill RA; Good RA
J Immunol; 2004 May; 172(9):5415-9. PubMed ID: 15100282
[TBL] [Abstract][Full Text] [Related]
14. Silica accelerated systemic autoimmune disease in lupus-prone New Zealand mixed mice.
Brown JM; Archer AJ; Pfau JC; Holian A
Clin Exp Immunol; 2003 Mar; 131(3):415-21. PubMed ID: 12605693
[TBL] [Abstract][Full Text] [Related]
15. A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice.
Zhu FG; Jiang W; Bhagat L; Wang D; Yu D; Tang JX; Kandimalla ER; La Monica N; Agrawal S
Autoimmunity; 2013 Nov; 46(7):419-28. PubMed ID: 24083389
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.
Sui W; Hou X; Che W; Chen J; Ou M; Xue W; Dai Y
Clin Immunol; 2013 Aug; 148(2):186-97. PubMed ID: 23770628
[TBL] [Abstract][Full Text] [Related]
17. Cognate interaction plays a key role in the surveillance of autoreactive B cells in induced mixed bone marrow chimerism in BXSB lupus mice.
Takeuchi E; Shinohara N; Takeuchi Y
Autoimmunity; 2011 Aug; 44(5):363-72. PubMed ID: 21244333
[TBL] [Abstract][Full Text] [Related]
18. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
19. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system.
Alexander T; Thiel A; Rosen O; Massenkeil G; Sattler A; Kohler S; Mei H; Radtke H; Gromnica-Ihle E; Burmester GR; Arnold R; Radbruch A; Hiepe F
Blood; 2009 Jan; 113(1):214-23. PubMed ID: 18824594
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice.
Gu F; Molano I; Ruiz P; Sun L; Gilkeson GS
Clin Immunol; 2012 Nov; 145(2):142-52. PubMed ID: 23041504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
